Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up y

被引：703
作者：
Pavel, M. [1 ]
Oberg, K. [2 ]
Falconi, M. [3 ]
Krenning, E. P. [4 ]
Sundin, A. [5 ]
Perren, A. [6 ]
Berruti, A. [7 ]
机构：
[1] Univ Hosp Erlangen, Dept Med 1, Erlangen, Germany
[2] Uppsala Univ, Dept Endocrine Oncol, Uppsala, Sweden
[3] IRCCS San Raffaele Sci Inst, Dept Surg, Milan, Italy
[4] Cyclotron Rotterdam BV, Erasmus Med Ctr, Rotterdam, Netherlands
[5] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden
[6] Univ Bern, Inst Pathol, Bern, Switzerland
[7] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Med Oncol Unit, ASST Spedali Civili, Brescia, Italy
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷 / 07期
关键词：
RECEPTOR RADIONUCLIDE THERAPY; ENETS CONSENSUS GUIDELINES; LIVER METASTASES; OCTREOTIDE-LAR; PHASE-III; GA-68-DOTA-TYR(3)-OCTREOTIDE PET; GASTROINTESTINAL-TRACT; TYR(3) OCTREOTATE; ENDOCRINE TUMORS; DOUBLE-BLIND;
D O I：
10.1016/j.annonc.2020.03.304
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：844 / 860
页数：17
相关论文
共 106 条
  • [101] Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
    Yao, James C.
    Fazio, Nicola
    Singh, Simron
    Buzzoni, Roberto
    Carnaghi, Carlo
    Wolin, Edward
    Tomasek, Jiri
    Raderer, Markus
    Lahner, Harald
    Voi, Maurizio
    Pacaud, Lida Buboteishvili
    Rouyrre, Nicolas
    Sachs, Carolin
    Valle, Juan W.
    Delle Fave, Gianfranco
    Van Cutsem, Eric
    Tesselaar, Margot
    Shimada, Yasuhiro
    Oh, Do-Youn
    Strosberg, Jonathan
    Kulke, Matthew H.
    Pavel, Marianne E.
    [J]. LANCET, 2016, 387 (10022) : 968 - 977
  • [102] Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
    Yao, James C.
    Shah, Manisha H.
    Ito, Tetsuhide
    Bohas, Catherine Lombard
    Wolin, Edward M.
    Van Cutsem, Eric
    Hobday, Timothy J.
    Okusaka, Takuji
    Capdevila, Jaume
    de Vries, Elisabeth G. E.
    Tomassetti, Paola
    Pavel, Marianne E.
    Hoosen, Sakina
    Haas, Tomas
    Lincy, Jeremie
    Lebwohl, David
    Oberg, Kjell
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06) : 514 - 523
  • [103] Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
    Yao, James C.
    Lombard-Bohas, Catherine
    Baudin, Eric
    Kvols, Larry K.
    Rougier, Philippe
    Ruszniewski, Philippe
    Hoosen, Sakina
    St Peter, Jessica
    Haas, Tomas
    Lebwohl, David
    Van Cutsem, Eric
    Kulke, Matthew H.
    Hobday, Timothy J.
    O'Dorisio, Thomas M.
    Shah, Manisha H.
    Cadiot, Guillaume
    Luppi, Gabriele
    Posey, James A.
    Wiedenmann, Bertram
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : 69 - 76
  • [104] Surgery for Pancreatic Neuroendocrine Tumor G3 and Carcinoma G3 Should be Considered Separately
    Yoshida, Tsukasa
    Hijioka, Susumu
    Hosoda, Waki
    Ueno, Makoto
    Furukawa, Masayuki
    Kobayashi, Noritoshi
    Ikeda, Masafumi
    Ito, Tetsuhide
    Kodama, Yuzo
    Morizane, Chigusa
    Notohara, Kenji
    Taguchi, Hiroki
    Kitano, Masayuki
    Yane, Kei
    Tsuchiya, Yoshiaki
    Komoto, Izumi
    Tanaka, Hiroki
    Tsuji, Akihito
    Hashigo, Syunpei
    Mine, Tetsuya
    Kanno, Atsushi
    Murohisa, Go
    Miyabe, Katsuyuki
    Takagi, Tadayuki
    Matayoshi, Nobutaka
    Sakaguchi, Masafumi
    Ishii, Hiroshi
    Kojima, Yasushi
    Matsuo, Keitaro
    Yoshitomi, Hideyuki
    Nakamori, Shoji
    Yanagimoto, Hiroaki
    Yatabe, Yasushi
    Furuse, Junji
    Mizuno, Nobumasa
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (05) : 1385 - 1393
  • [105] Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors
    Zandee, Wouter T.
    Brabander, Tessa
    Blazevic, Anela
    Kam, Boen L. R.
    Teunissen, Jaap J. M.
    Feelders, Richard A.
    Hofland, Johannes
    de Herder, Wouter W.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (04) : 1336 - 1344
  • [106] Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients
    Zhang, Jingjing
    Kulkarni, Harshad R.
    Singh, Aviral
    Niepsch, Karin
    Mueller, Dirk
    Baum, Richard P.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (03) : 377 - 385
234567891011